Y. Ota, T. Kodaira, H. Fujii, M. Shimokawa, T. Nakashima, N. Monden, T. Yokota, A. Homma, S. Ueda, T. Akimoto
{"title":"西妥昔单抗(JROSG12-2)治疗日本局部晚期头颈部鳞状细胞癌患者的前瞻性观察研究:安全性和治疗依从性的中期评价","authors":"Y. Ota, T. Kodaira, H. Fujii, M. Shimokawa, T. Nakashima, N. Monden, T. Yokota, A. Homma, S. Ueda, T. Akimoto","doi":"10.5981/jjhnc.45.330","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38497,"journal":{"name":"Japanese Journal of Head and Neck Cancer","volume":"48 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A prospective observation study of Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated by radiotherapy with cetuximab (JROSG12-2): interim appraisal of the safety and treatment compliance\",\"authors\":\"Y. Ota, T. Kodaira, H. Fujii, M. Shimokawa, T. Nakashima, N. Monden, T. Yokota, A. Homma, S. Ueda, T. Akimoto\",\"doi\":\"10.5981/jjhnc.45.330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":38497,\"journal\":{\"name\":\"Japanese Journal of Head and Neck Cancer\",\"volume\":\"48 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese Journal of Head and Neck Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5981/jjhnc.45.330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Head and Neck Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5981/jjhnc.45.330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
A prospective observation study of Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated by radiotherapy with cetuximab (JROSG12-2): interim appraisal of the safety and treatment compliance